Sponsors (3)
Introduced December 10, 2025 by Kathy Castor · Last progress December 10, 2025
The bill directs meaningful federal investment into HPV vaccination outreach and substantially expands screening funding to reduce cancers and racial/rural disparities, but it requires new federal spending and its impact depends on effective implementation, appropriation, and the ability to overcome vaccine hesitancy.
Women — the bill authorizes $300 million per year (FY2026–2030) to expand breast and cervical cancer screening and early detection, improving survival and reducing later treatment costs.
Adolescents, young adults, and communities with low uptake — a sustained national HPV vaccination and screening campaign (with $5M/year FY2026–2030 plus grant funding) is likely to raise awareness, increase vaccine initiation/series completion, and improve screening uptake.
Racial/ethnic minorities, veterans, and rural populations — the bill funds culturally and linguistically tailored resources and targeted outreach that can reduce observed disparities in vaccination and HPV-associated cancers.
Taxpayers — the bill authorizes new federal spending (about $305 million per year combined: $300M for screening + $5M for the campaign), increasing federal outlays that compete with other priorities.
Women, clinics, and health systems — if the authorized funding is not actually appropriated, promised screening expansions may not materialize, creating uncertainty for clinics and patients planning services.
Children, parents, and young adults — the media/messaging campaign may fail to overcome entrenched vaccine hesitancy in some communities, limiting real-world increases in vaccination despite funding.
Based on analysis of 4 sections of legislative text.
Creates a CDC-funded national HPV vaccine awareness campaign and raises authorized funding for breast and cervical cancer screening ($300M/year FY2026–2030).
Requires the Department of Health and Human Services, through the CDC, to run a national public awareness campaign to promote HPV vaccination, counter misinformation, and raise completion of the HPV vaccine series, with grants to nonprofits and to state, local, and Tribal health departments for community outreach. It also increases funding for the federal Breast and Cervical Cancer Early Detection Program by adding $300 million per year for fiscal years 2026–2030 and authorizes $5 million per year for the HPV awareness campaign over the same period. The law directs tailored materials for specific groups (e.g., adolescents, males, Black and Hispanic women, rural communities, service members and veterans), distribution to health providers and schools, coordination with other federal screening and vaccination efforts (including self-collection screening), and requires a qualitative report on campaign activities by September 30, 2027.